---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-158493"
form_type: "8-K"
ticker: "PRGO"
cik: "0001585364"
company_name: "PERRIGO Co plc"
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:39:17.795729+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Perrigo to sell Dermacosmetics business to KKR for up to €327M

## Summary
- Upfront cash €300M, plus up to €27M milestone payments over three years.
- Divestiture includes brands ACO, Biodermal, Emolium, Iwostin; 2024 net sales ~€125M.
- Expected to close Q1 2026; net proceeds to strengthen balance sheet.
- Advances Perrigo's 'Three-S' plan to streamline portfolio and focus on high-growth brands.
- Business generated ~5% of Perrigo's 2024 adjusted operating income.

## SEC filing metadata
- accession: 0001193125-25-158493
- form_type: 8-K
- ticker: PRGO
- cik: 0001585364
- company_name: PERRIGO Co plc
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585364/000119312525158493/0001193125-25-158493-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585364/000119312525158493/d89351d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-158493
- JSON: https://secwatch.observer/filing/0001193125-25-158493.json
- Plain text: https://secwatch.observer/filing/0001193125-25-158493.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.